NFKB1 and neoplasm: To the best of our knowledge, this is the first study to date to show the anti-inflammatory and anti-tumor impacts of Calebin A on multicellular pro-inflammatory TME, at least in part through targeting the suppression of the NF-κB signaling pathway.